A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population

A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population

Yusuf Yazici,1 Lin Xie,2 Adesuwa Ogbomo,2 Lorie A Ellis,3 Kavitha Goyal,4 Amanda Teeple,5 Ece A Mutlu,6 Ismail Simsek7 1Department of Internal Medicine, Division of Rheumatology, New York University Hospital for Joint Diseases, New York, NY, USA; 2STATinMED Research, Health Economics and Outcomes Re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Mutlu EA, Simsek I
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Discontinuation
switch
inflammatory bowel disease
rheumatoid arthritis
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/a46f2b294146462c85a0c81712b86f9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares